Introduction Mental health disorders affect millions globally, with depression, anxiety, PTSD, and other conditions continuing to challenge conventional treatment methods. Despite advances in pharmacology, a significant number of patients remain treatment-resistant, prompting researchers and wellness communities to explore alternative therapies. Among these, Ibogaine and Psilocybin microdosing have emerged as promising solutions for both clinical and […]